VCA Specialty Update Symposium
SUNDAY 13 SEPTEMBER
09:00 – 12:50 VCA Specialty Update Symposium
CHAIRS: Lionel Badet, Lyon, France
Emmanuel Morelon, Paris, France
09:00 Limitations and results of face transplantation
Sylvie Testelin, Amiens, France
09:30 Limitations and results of upper limb transplantation
Stefan Schneeberger, Innsbruck, Austria
10:00 Laryngeal and Tracheal transplantation
Pierre Delaere, Leuven, Belgium
10:40 – 11:10 Coffee Break
SESSION 2: Joint Session Basic Science & Vascularized Composite Allotransplantation
CHAIRS: Pietro Cippà, Zurich, Switzerland
Henri Leuvenink, Groningen, The Netherlands
11:10 Chronic rejection in VCA: from myth to reality
Olivier Thaunat, Lyon, France
11:40 Cell-based therapy options in VCA
Jan Plock, Zurich, Switzerland
12:10 What have we learned from animal models in VCA?
Gerald Brandacher, Baltimore, United States
_________________________________________________________________________________________________________________________
VCA in pills:
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This committee brings together 10 representatives of major European teams at the forefront in this field.
Goals:
Our goal is to raise the scientific and clinical development of Vascularized Composite Allotransplantation (VCA) in Europe and to serve as a platform for scientists and clinicians for information and exchange.
Objectives:
- Understand the risks and limits of face and upper limb transplantation
- Discuss and implement new data to characterize chronic rejection
- Discuss the contribution of animal models in VCA
- Discuss alternatives strategies for patients’ management
Target audience:
Surgeons, physicians, researchers, transplant coordinators
Information
Contact
ESOT Office Riviera dei Mugnai, 8/24 35137 Padova Italy |
esot2015@esot.org T: +39 049 859 7652 F: +39 049 210 6306 |